ATE365741T1 - Synthetische metall-substituierte bacteriochloropyllderivate und ihre verwendung - Google Patents

Synthetische metall-substituierte bacteriochloropyllderivate und ihre verwendung

Info

Publication number
ATE365741T1
ATE365741T1 AT96938445T AT96938445T ATE365741T1 AT E365741 T1 ATE365741 T1 AT E365741T1 AT 96938445 T AT96938445 T AT 96938445T AT 96938445 T AT96938445 T AT 96938445T AT E365741 T1 ATE365741 T1 AT E365741T1
Authority
AT
Austria
Prior art keywords
bchl
bacterio
synthetic
metallated
metal
Prior art date
Application number
AT96938445T
Other languages
German (de)
English (en)
Inventor
Avigdor Scherz
Yoram Salomon
Hugo Scheer
Gerhard Hartwich
Alexander Brandis
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE365741T1 publication Critical patent/ATE365741T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96938445T 1995-11-24 1996-11-24 Synthetische metall-substituierte bacteriochloropyllderivate und ihre verwendung ATE365741T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11612695A IL116126A0 (en) 1995-11-24 1995-11-24 Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
ATE365741T1 true ATE365741T1 (de) 2007-07-15

Family

ID=11068225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96938445T ATE365741T1 (de) 1995-11-24 1996-11-24 Synthetische metall-substituierte bacteriochloropyllderivate und ihre verwendung

Country Status (18)

Country Link
US (1) US6333319B1 (OSRAM)
EP (1) EP0863903B1 (OSRAM)
JP (1) JP2000500763A (OSRAM)
CN (1) CN1085211C (OSRAM)
AT (1) ATE365741T1 (OSRAM)
AU (1) AU718961B2 (OSRAM)
BR (1) BR9611452A (OSRAM)
DE (1) DE69637149T2 (OSRAM)
DK (1) DK0863903T3 (OSRAM)
ES (1) ES2288757T3 (OSRAM)
HU (1) HU223379B1 (OSRAM)
IL (1) IL116126A0 (OSRAM)
MX (1) MX9804143A (OSRAM)
NO (1) NO323478B1 (OSRAM)
PL (1) PL188811B1 (OSRAM)
PT (1) PT863903E (OSRAM)
RU (1) RU2193038C2 (OSRAM)
WO (1) WO1997019081A1 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413436B1 (en) * 1999-01-27 2002-07-02 Semitool, Inc. Selective treatment of the surface of a microelectronic workpiece
PL201172B1 (pl) * 1998-12-09 2009-03-31 Yeda Res & Dev Pd-Bakteriofeoforbid, sposób jego wytwarzania, kompozycja farmaceutyczna zawierająca go i jego zastosowanie
IL133253A0 (en) * 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
US7045117B2 (en) * 1999-12-01 2006-05-16 Yeda Research And Development Co. Ltd. Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives
EP1318807A4 (en) * 2000-08-11 2008-02-20 Ceramoptec Gmbh LIGHT-SENSITIVE OINTMENT
RU2183956C1 (ru) * 2001-03-30 2002-06-27 Общество с ограниченной ответственностью "РАДА-ФАРМА" Фотосенсибилизатор и способ его получения
EP1277470A1 (fr) * 2001-07-17 2003-01-22 Steba Biotech N.V. Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation
IL148921A0 (en) * 2002-03-26 2002-09-12 Peptor Ltd Photo active backbone cyclized somatostatin analogs for optical imaging and photodynamic therapy
JP2005524461A (ja) 2002-05-08 2005-08-18 イエダ リサーチ アンド デベロップメント カンパニー リミテッド 増感オンラインbold−mriイメージング法
CN2595398Y (zh) 2002-09-25 2003-12-31 王健 动态加静态磁脉冲理疗仪
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
WO2005120572A1 (en) 2004-06-09 2005-12-22 Qlt Inc. Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
ES2602460T3 (es) * 2004-06-07 2017-02-21 Yeda Research And Development Co., Ltd. Derivados de bacterioclorofila catiónicos y usos de los mismos
WO2008018063A2 (en) * 2006-08-07 2008-02-14 Kodesh S.A Tetraarylporphine derivatives and uses thereof
DK2061512T3 (da) * 2006-08-23 2020-01-20 Yeda Res & Dev Konjugater af rgd-peptider og (bakterie)chlorophylfotosensibilisatorer samt anvendelser deraf
KR20090113908A (ko) * 2007-02-23 2009-11-02 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 금속단백질 활성 억제용 항체 및 이를 함유하는 약학적 조성물
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
EP2244787A1 (en) * 2008-01-28 2010-11-03 Yeda Research And Development Company Ltd. Endoscopic imaging photodynamic therapy system and methods of use
AU2009219682B2 (en) 2008-02-27 2015-06-18 Yeda Research & Development Co. Ltd RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
RU2415868C1 (ru) * 2009-09-10 2011-04-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Производные гемина, обладающие антимикробной активностью, или их фармацевтически приемлемые соли, способ получения, фармкомпозиция и применение
CN102584837A (zh) * 2012-01-18 2012-07-18 河北联合大学 天然叶绿素铁铬盐及制备方法
CN103405769A (zh) * 2013-03-07 2013-11-27 北京亿仁赛博医疗科技研发中心有限公司 光敏剂在制备治疗疾病的病毒灭活药物中的应用
DK2971026T3 (da) 2013-03-11 2021-02-15 Tookad Ip Sarl Fremgangsmåde til produktion af bakterieklorofyl a
CN109679110B (zh) * 2018-12-25 2020-10-09 北京科技大学 一种基于菌绿素的纳米金属-有机框架光敏剂及制备方法
CN114005684B (zh) * 2021-11-05 2023-05-05 吉林大学 不饱和叶绿素的电化学聚合薄膜及其在超级电容器上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE4121876A1 (de) * 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US5591847A (en) * 1994-05-23 1997-01-07 Health Research, Inc. Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages

Also Published As

Publication number Publication date
DE69637149T2 (de) 2008-02-28
PL188811B1 (pl) 2005-04-29
DE69637149D1 (de) 2007-08-09
ES2288757T3 (es) 2008-01-16
DK0863903T3 (da) 2007-09-24
NO982348D0 (no) 1998-05-22
EP0863903B1 (en) 2007-06-27
IL116126A0 (en) 1996-01-31
HUP9903582A2 (hu) 2000-02-28
RU2193038C2 (ru) 2002-11-20
JP2000500763A (ja) 2000-01-25
CN1085211C (zh) 2002-05-22
NO323478B1 (no) 2007-05-21
CN1207741A (zh) 1999-02-10
MX9804143A (es) 1998-09-30
EP0863903A1 (en) 1998-09-16
PT863903E (pt) 2007-09-07
AU7585796A (en) 1997-06-11
BR9611452A (pt) 1999-02-17
US6333319B1 (en) 2001-12-25
HU223379B1 (hu) 2004-06-28
HUP9903582A3 (en) 2002-02-28
WO1997019081A1 (en) 1997-05-29
AU718961B2 (en) 2000-05-04
NO982348L (no) 1998-07-23
PL326745A1 (en) 1998-10-26

Similar Documents

Publication Publication Date Title
ATE365741T1 (de) Synthetische metall-substituierte bacteriochloropyllderivate und ihre verwendung
US4830716B1 (en) Preparation of pharmaceutical grade amino acid chelates
Kizilcikli et al. Antimicrobial activity of a series of thiosemicarbazones and their ZnII and PdII complexes
DE3687399D1 (de) Porphyrinderivate, ihre herstellung und verwendung.
CA2045843A1 (en) Process for the preparation of dialkyl carbonates
RU95117718A (ru) Катализатор и способ получения азота из аммиаксодержащего отходящего газа
ZA867440B (en) Novel process for the synthesis of amikacin
Preti et al. Study of the nature of metal—ligand bond in zinc, cadmium and mercury areneseleninato complexes
IL78341A0 (en) Method of preparing 2,3,6-trichloropyridine and 2,3,5,6-tetrachloropyridine in the gas phase
RU96121458A (ru) Способ каталитического связывания двуокиси углерода
Yamada et al. Oxygenation of 2, 6-di-t-butylphenol catalysed by a new cobalt (II) complex [Co (babp)]: a salen analogue having higher catalytic activity, selectivity, and durability
Karaböcek et al. Copper (II)–nickel (II) complexes of novel 1, 9-dioxa-3, 6-dithiacyclotridecane-10, 12-dione and 1, 4-dioxa-7, 10-dithiacyclododecane-2, 3-dione ligands
Yusuff et al. Synthesis of new mixed ligand complexes of copper (II) dithiocarbamates
Ogoshi et al. PREPARATION AND CHARACTERIZATION OF IRON (III) COMPLEXES OF N-METHYLOCTAETHYLPORPHYRIN
PL234152A1 (OSRAM)
SU1664794A1 (ru) Способ получени 2,2 @ ,4-триметил-1,3-дитиолана
Gaete et al. Complexes of N-methyl-4-mercaptopiperidine with some metal ions
ES8303347A1 (es) "procedimiento para la preparacion de amino-pridinas".
Adeyemo et al. A cobalt (II) complex of vitamin B1
US3712894A (en) Pyridine-organocopper product and preparation
UA137237U (uk) Застосування комплексу на основі n-оксиду-2-метилпіридину і хлориду міді як інгібітора окиснення ароматичних спиртів
Wilson et al. Narcotic Analgesics: Possibility of Broadening the Structural Basis of Analgesics
JPS5490189A (en) Preparation of carboxylic acid polynuclear metal complex
RU93019809A (ru) Тетрофтортетраазапорфин
MA et al. Some glyoxal bis [thiosemicarbazone] copper [II] chelates of pronounced antimicrobial activity

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0863903

Country of ref document: EP

REN Ceased due to non-payment of the annual fee